Coloplast A/S (CLPBY)
7.348
-0.13
(-1.77%)
USD |
OTCM |
Nov 18, 16:00
Coloplast Market Cap : 15.24B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 15.24B |
| November 17, 2026 | 15.51B |
| November 16, 2026 | 15.47B |
| November 13, 2026 | 15.53B |
| November 12, 2026 | 15.10B |
| November 11, 2026 | 15.26B |
| November 10, 2026 | 15.18B |
| November 09, 2026 | 15.64B |
| November 06, 2026 | 15.74B |
| November 05, 2026 | 16.26B |
| November 04, 2026 | 16.44B |
| November 03, 2026 | 15.30B |
| November 02, 2026 | 14.00B |
| October 30, 2026 | 15.01B |
| October 29, 2026 | 14.93B |
| October 28, 2026 | 14.91B |
| October 27, 2026 | 14.87B |
| October 26, 2026 | 15.03B |
| October 23, 2026 | 15.20B |
| October 22, 2026 | 15.01B |
| October 21, 2026 | 14.72B |
| October 20, 2026 | 14.91B |
| October 19, 2026 | 14.64B |
| October 16, 2026 | 14.68B |
| October 15, 2026 | 14.60B |
| Date | Value |
|---|---|
| October 14, 2026 | 14.27B |
| October 13, 2026 | 14.37B |
| October 12, 2026 | 13.96B |
| October 09, 2026 | 13.69B |
| October 08, 2026 | 13.40B |
| October 07, 2026 | 13.29B |
| October 06, 2026 | 13.17B |
| October 05, 2026 | 12.92B |
| October 02, 2026 | 12.82B |
| October 01, 2026 | 12.98B |
| September 30, 2026 | 13.11B |
| September 29, 2026 | 13.29B |
| September 28, 2026 | 13.38B |
| September 25, 2026 | 13.40B |
| September 24, 2026 | 13.35B |
| September 23, 2026 | 13.31B |
| September 22, 2026 | 13.40B |
| September 21, 2026 | 13.42B |
| September 18, 2026 | 13.38B |
| September 17, 2026 | 13.50B |
| September 16, 2026 | 13.38B |
| September 15, 2026 | 13.52B |
| September 14, 2026 | 13.58B |
| September 11, 2026 | 13.62B |
| September 10, 2026 | 14.00B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ambu A/S | 3.010B |
| Abbott Laboratories | 180.95B |
| AngioDynamics, Inc. | 480.24M |
| Alphatec Holdings, Inc. | 1.083B |
| AtriCure, Inc. | 2.823B |
Market Cap Related Metrics
| PE Ratio | 34.82 |
| PS Ratio | 3.680 |
| Price to Book Value | 7.625 |
| Price to Free Cash Flow | 16.53 |
| Price | 7.348 |
| Earnings Yield | 2.87% |
| Operating PE Ratio | 14.46 |
| Normalized PE Ratio | 20.34 |